Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Bitler

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 17, 2022
Expression and T cell regulatory action of the PD-1 immune checkpoint in the ovary and fallopian tubeJoshua Johnson, So-Youn Kim, Peter Ka Sam, et al.
Diagnostics (Basel, Switzerland)|September 13, 2025
Clinical Evaluation of a Multi-Omic Diagnostic Model for Early-Stage Ovarian Cancer DetectionRobert A Law, Brendan M Giles, Rachel Culp-Hill, et al.
Molecular Cancer Therapeutics|June 12, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Cell|December 13, 2024
Regulation of human interferon signaling by transposon exonizationGiulia Irene Maria Pasquesi, Holly Allen, Atma Ivancevic, et al.
Molecular Cancer Therapeutics|May 7, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Regulation of human interferon signaling by transposon exonizationGiulia Irene Maria Pasquesi, Holly Allen, Atma Ivancevic, et al.
Iscience|August 23, 2019
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer DisseminationLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
Nature Cell Biology|July 25, 2017
ARID1A-mutated ovarian cancers depend on HDAC6 activityBenjamin G Bitler, Shuai Wu, Pyoung Hwa Park, et al.
Molecular Cancer Research : MCR|August 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent MannerLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Cancer Research|November 3, 2016
BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian CancerYuhki Yokoyama, Hengrui Zhu, Jeong Heon Lee, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 17, 2022
Expression and T cell regulatory action of the PD-1 immune checkpoint in the ovary and fallopian tubeJoshua Johnson, So-Youn Kim, Peter Ka Sam, et al.
Diagnostics (Basel, Switzerland)|September 13, 2025
Clinical Evaluation of a Multi-Omic Diagnostic Model for Early-Stage Ovarian Cancer DetectionRobert A Law, Brendan M Giles, Rachel Culp-Hill, et al.
Molecular Cancer Therapeutics|June 12, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Cell|December 13, 2024
Regulation of human interferon signaling by transposon exonizationGiulia Irene Maria Pasquesi, Holly Allen, Atma Ivancevic, et al.
Molecular Cancer Therapeutics|May 7, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Regulation of human interferon signaling by transposon exonizationGiulia Irene Maria Pasquesi, Holly Allen, Atma Ivancevic, et al.
Iscience|August 23, 2019
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer DisseminationLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
Nature Cell Biology|July 25, 2017
ARID1A-mutated ovarian cancers depend on HDAC6 activityBenjamin G Bitler, Shuai Wu, Pyoung Hwa Park, et al.
Molecular Cancer Research : MCR|August 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent MannerLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Cancer Research|November 3, 2016
BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian CancerYuhki Yokoyama, Hengrui Zhu, Jeong Heon Lee, et al.
Pageof 12